Mo et al.
FULL PAPER
-
1
1649, 1462, 1452, 1371, 1302, 1086, 1065, 1017, 831,
1356, 1313, 1285, 1246, 1167, 1014, 730 cm ; EI-MS
(m/z, relative intensity): 474 (3), 374 (8), 283 (7), 218
(9), 91 (100), 57 (21), 41 (44). HRMS (ESI) calcd for
C28H30N4O5Na (M+Na) 525.2108, found 525.2130.
-
1
730 cm ; EI-MS (m/z, relative intensity): 390 (13), 374
(4), 333 (5), 299 (5), 218 (7), 124 (7), 91 (100), 65 (11),
28 (71); HRMS (ESI) calcd for C30H29N4O4S (M+H)
541.19040, found 541.1909.
(R)-tert-Butyl 2-(5-(allyloxy)-1-(tert-butoxycarbon-
ylamino)-4-diazo-3,5-dioxopent-yl)-1H-indole-1-car-
boxylate (18)
tert-Butyl 2-((R)-5-(allyloxy)-4-diazo-1-((S)-4-methyl
phenylsulfinamido)-3,5-dioxopentyl)-1H-indole-1-
carboxylate (17)
Yellow solid, 94% yield, [α]2D0 +45.0 (c 1.45 in
CHCl3); 1H NMR (300 MHz, CDCl3) δ: 8.04 (d, J=8.4
Hz, 1H), 7.47 (d, J=7.2 Hz, 1H), 7.27—7.16 (m, 2H),
6.61 (s, 1H), 6.05 (d, J=9.0 Hz, 1H), 5.93—5.80 (m,
2H), 5.32—5.24 (m, 2H), 4.65 (d, J=5.7 Hz, 2H), 3.73
(dd, J=16.2, 6.0 Hz, 1H), 3.34 (dd, J=15.9, 5.1 Hz,
1H), 1.72 (s, 9H), 1.43 (s, 9H); 13C NMR (75 MHz,
CDCl3) δ: 190.3, 160.6, 154.8, 150.3, 140.4, 136.7,
131.2, 128.5, 124.0, 122.7, 120.5, 119.1, 115.6, 108.7,
84.6, 79.4, 65.8, 46.6, 43.7, 28.3, 28.1; IR (film) ν: 2977,
2926, 2136, 1718, 1652, 1488, 1453, 1368, 1327, 1158,
1116, 1085, 1054, 911, 769, 735 cm ; EI-MS (m/z,
relative intensity): 384 (5), 328 (15), 284 (16), 270 (15),
226 (10), 145 (20), 57 (100), 41 (71). HRMS (ESI)
calcd for C26H32N4O7Na (M+Na) 535.2163, found
535.2160.
Dark red solid, 73% yield, [α]2D0 +92.4 (c 1.0 in
CHCl3); 1H NMR (300 MHz, CDCl3) δ: 8.04—8.01 (m,
1H), 7.31 (d, J=8.4 Hz, 2H), 7.50—7.47 (m, 1H),
7.28—7.25 (m, 3H), 7.22—7.16 (m, 1H), 6.68 (s, 1H),
5.96—5.83 (m, 1H), 5.70—5.54 (m, 2H), 5.35—5.25
(m, 2H), 4.66 (dt, J=5.7, 1.2 Hz, 2H), 3.78—3.71 (m,
1H), 3.51 (dd, J=16.8, 5.7 Hz, 1H), 2.39 (s, 3H), 1.69
(s, 9H); 13C NMR (75 MHz, CDCl3) δ: 189.8, 160.6,
150.5, 142.2, 141.1, 140.8, 136.7, 131.3, 129.3, 128.5,
125.6, 124.3, 122.8, 120.7, 119.2, 115.7, 109.4, 84.8,
65.8, 50.2, 45.2, 28.1, 21.3; IR (film) ν: 2977, 2926,
2139, 1719, 1650, 1453, 1370, 1326, 1304, 1213, 1156,
1117, 1090, 1065, 910, 810, 768, 734 cm ; EI-MS (m/z,
relative intensity): 300 (17), 284 (15), 267 (10), 246
(38), 209 (23), 170 (23), 144 (24), 124 (65), 91 (100),
77 (24), 44 (73), 39 (47); HRMS (ESI) calcd for
C28H31N4O6S (M+H) 551.1959, found 551.1965.
-
1
-
1
(5R)-3-Allyl N-tert-butyl 5-(1-(tert-butoxycarbonyl)-
1H-indol-2-yl)-2-oxopyrrolidine-1,3-dicarboxylate
(19)
General procedures for preparation of diazoesters 11
and 18
N-Boc protected diazoester (18) was dissolved in
benzene and subjected to irradiation (500 W, Hg lamp,
Pyrex tube) under stirring. The system was kept at room
temperature by cooling water condenser and the irradia-
tion was kepted for 4 h until no IR signal of diazo moi-
The addition product (10) or (17) was dissolved in
methanol and cooled to 0 ℃. Trifluoroacetic acid (TFA,
5.0 equiv.) was added to the solution and the ice-water
bath was removed. The system was warmed to room
temperature gradually and was stirred for another 2 h.
The solvent was removed by evaporating under vacuum
and the crude residue was dissolved in THF and cooled
to 0 ℃. Triethyl amine (6 equiv.), Boc2O (1.2 equiv.)
and N',N'-dimethylaminopyridine (5 mol%) were added
to the solution. Then ice-water bath was taken away and
the mixture was stirred for another 2 h at room tem-
perature. Solvent was removed by evaporation under
vacuum and the residue was purified by flash column
chromatography (petroleum∶ethyl acetate = 10∶1,
V∶V) on silica gel to yield N-Boc protected diazoester
11 or 18.
ety in around 2100 cm- could be observed. The mix-
1
ture was then transferred to round-bottomed flask. Sol-
vent was removed by evaporation under vacuum and the
residue was purified by flash column chromatography
(petroleum∶ethyl acetate=10∶1, V∶V) on silica gel
to afford 2-oxopyrrolidine (19). Yield 64%, colorless oil;
1H NMR (300 MHz, CDCl3) δ: 8.09—8.01 (m, 1H),
7.49—7.42 (m, 1H), 7.32—7.18 (m, 2H), 6.42 (s, 1H),
6.04 (d, J = 8.7 Hz, 1H), 5.98—5.85 (m, 1H),
5.40—5.06 (m, 2H), 4.75—4.42 (m, 2H), 3.71 (dd, J=
12.3, 8.4 Hz, 1H), 2.96—2.85 (m, 1H), 2.54—2.30 (m,
1H), 1.71 (s, 9H), 1.44 (s, 9H); 13C NMR (75 MHz,
CDCl3) δ: 168.8, 168.1, 149.9, 149.2, 139.9, 136.6,
131.3, 131.2, 128.2, 124.3, 123.1, 120.4, 118.7, 115.6,
115.6, 105.7, 105.6, 84.8, 83.6, 66.2, 54.8, 54.7, 47.9,
47.9, 29.5, 28.1, 27.7, 27.6; IR (film) ν: 2932, 1790,
1730, 1454, 1369, 1328, 1290, 1250, 1148, 1117, 1084,
(R)-Allyl 5-(1-benzyl-1H-indol-2-yl)-5-(tert-butoxy-
carbonylamino)-2-diazo-3-oxopentanoate (11)
Yellow solid, 95% yield, [α]2D0 +80.5 (c 1.0 in
CHCl3); 1H NMR (300 MHz, CDCl3) δ: 7.58—7.56 (m,
1H), 7.25—7.10 (m, 5H), 7.09—7.00 (m, 3H), 6.46 (s,
1H), 5.99—5.86 (m, 1H), 5.51—5.43 (m, 3H),
5.37—5.28 (m, 2H), 4.88 (d, J=8.1 Hz, 1H), 4.70 (d,
J=5.4 Hz, 2H), 3.67 (dd, J=15.9, 9.3 Hz, 1H), 3.38
(dd, J=15.9, 9.3 Hz, 1H), 1.29 (s, 9H); 13C NMR (75
MHz, CDCl3) δ: 189.3, 160.9, 154.3, 139.6, 137.6,
137.3, 131.2, 128.5, 127.2, 127.0, 126.0, 122.0, 120.5,
119.7, 119.1, 109.9, 99.6, 79.6, 65.8, 46.6, 44.7, 43.7,
28.0; IR (film) ν: 3346, 2141, 1718, 1678, 1517, 1464,
-
1
913, 848, 769, 739 cm ; EI-MS (m/z, relative intensity):
484 (6), 384 (10), 328 (7), 284 (68), 226 (39), 199 (21),
171 (14), 51 (100), 41 (68). HRMS (ESI) calcd for
C26H32N2O7Na (M+Na) 507.2102, found 507.2101.
(R)-tert-Butyl 2-(1-(tert-butoxycarbonyl)-5-oxo-
pyrrolidin-2-yl)-1H-indole-1-carboxylate (20)
Wolff rearrangement product (19) (454 mg, 0.94
mmol) was dissolved in 20 mL THF at room tempera-
2300
© 2012 SIOC, CAS, Shanghai, & WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim
Chin. J. Chem. 2012, 30, 2297—2302